Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.36 USD | +3.97% | +12.38% | -31.79% |
09/05 | Nephros, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
09/05 | Transcript : Nephros, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Sales 2024 * | 15.99M 1.33B | Sales 2025 * | 18.05M 1.5B | Capitalization | 24.88M 2.07B |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | - 0 | EV / Sales 2024 * | 1.56 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.38 x |
P/E ratio 2024 * |
-67.4
x | P/E ratio 2025 * |
59
x | Employees | 31 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.77% |
Latest transcript on Nephros, Inc.
1 day | +3.97% | ||
1 week | +12.38% | ||
Current month | +5.83% | ||
1 month | +16.26% | ||
3 months | -32.82% | ||
6 months | +15.13% | ||
Current year | -31.79% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Banks
CEO | Chief Executive Officer | 49 | 31/23/31 |
Judy Krandel
DFI | Director of Finance/CFO | 59 | 01/11 |
Alfred Vargas
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Amron
BRD | Director/Board Member | 67 | 19/07/19 |
Oliver Spandow
BRD | Director/Board Member | 52 | 10/18/10 |
Alisa Lask
BRD | Director/Board Member | 53 | 08/19/08 |
Date | Price | Change | Volume |
---|---|---|---|
17/24/17 | 2.36 | +3.97% | 60,174 |
16/24/16 | 2.27 | +10.73% | 64,409 |
15/24/15 | 2.05 | -3.76% | 5,789 |
14/24/14 | 2.13 | +1.43% | 9,918 |
13/24/13 | 2.1 | 0.00% | 8,811 |
Delayed Quote Nasdaq, May 18, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.79% | 24.88M | |
+12.90% | 8.88B | |
+41.27% | 2.44B | |
-10.44% | 1.02B | |
+22.34% | 867M | |
-6.54% | 782M | |
+23.40% | 726M | |
+23.74% | 715M | |
-16.27% | 592M | |
-5.06% | 576M |
- Stock Market
- Equities
- NEPH Stock